These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3136278)

  • 21. The effects of aldose reductase inhibitors in diabetic nephropathy.
    McCormack AJ; Finn WF
    J Diabet Complications; 1989; 3(1):18-26. PubMed ID: 2523401
    [No Abstract]   [Full Text] [Related]  

  • 22. Lens aldose reductase in diabetic and galactosemic cataracts.
    Parmar NS; Ghosh MN
    Indian J Physiol Pharmacol; 1981; 25(3):193-200. PubMed ID: 6795119
    [No Abstract]   [Full Text] [Related]  

  • 23. Aldose reductase localization in dog retinal mural cells.
    Akagi Y; Terubayashi H; Millen J; Kador PF; Kinoshita JH
    Curr Eye Res; 1986 Nov; 5(11):883-6. PubMed ID: 3096638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutathione redox state is not the link between polyol pathway activity and myo-inositol-related Na+-K+-ATPase defect in experimental diabetic neuropathy.
    Carroll PB; Thornton BM; Greene DA
    Diabetes; 1986 Nov; 35(11):1282-5. PubMed ID: 3019809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldose reductase inhibitors.
    Kirchain WR; Rendell MS
    Pharmacotherapy; 1990; 10(5):326-36. PubMed ID: 2122421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M; Sharma YR; Cotlier E; Hollander JD
    Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic neuropathy in db/db mice develops independently of changes in ATPase and aldose reductase. A biochemical and immunohistochemical study.
    Bianchi R; Marelli C; Marini P; Fabris M; Triban C; Fiori MG
    Diabetologia; 1990 Mar; 33(3):131-6. PubMed ID: 2158468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldose reductase in diabetic cataracts.
    Kinoshita JH; Kador P; Catiles M
    JAMA; 1981 Jul; 246(3):257-61. PubMed ID: 6787220
    [No Abstract]   [Full Text] [Related]  

  • 29. Human liver 6-pyruvoyl tetrahydropterin reductase is biochemically and immunologically indistinguishable from aldose reductase.
    Steinerstauch P; Wermuth B; Leimbacher W; Curtius HC
    Biochem Biophys Res Commun; 1989 Nov; 164(3):1130-6. PubMed ID: 2511841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes: response to Wang et al.
    P K Ng D; Chia KS; Koh D
    Diabetes Care; 2004 Jan; 27(1):289-90; author reply 290. PubMed ID: 14694018
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of the active sites of aldose reductase and aldehyde reductase from chicken.
    Davidson WS
    Prog Clin Biol Res; 1987; 232():275-85. PubMed ID: 3112782
    [No Abstract]   [Full Text] [Related]  

  • 32. Aldose and aldehyde reductase in animal tissues.
    Flynn TG
    Metabolism; 1986 Apr; 35(4 Suppl 1):105-8. PubMed ID: 3083200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symposium: Aldose reductase and the complications of diabetes mellitus: reviews of preclinical studies in eyes, nerves, and kidneys. London, September 1984. Proceedings.
    Diabet Med; 1985 May; 2(3):185-212. PubMed ID: 2952416
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of transgenic expression of human aldose reductase on diabetic complications].
    Ii S; Itakura M
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():753-7. PubMed ID: 9513508
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of aldose reductase inhibitors in diabetic complications: recent trends.
    Kaul CL; Ramarao P
    Methods Find Exp Clin Pharmacol; 2001 Oct; 23(8):465-75. PubMed ID: 11838322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased renal aldose reductase activity, immunoreactivity, and mRNA in streptozocin-induced diabetic rats.
    Ghahary A; Luo JM; Gong YW; Chakrabarti S; Sima AA; Murphy LJ
    Diabetes; 1989 Aug; 38(8):1067-71. PubMed ID: 2526763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aldose reductase inhibition in diabetes.
    Clarke BF; Young RJ; Martyn CN; Ewing DJ
    Diabet Med; 1984 Jul; 1(2):88-90. PubMed ID: 6242793
    [No Abstract]   [Full Text] [Related]  

  • 38. Aldose reductase and polyol in cultured pericytes of human retinal capillaries.
    Hohman TC; Nishimura C; Robison WG
    Exp Eye Res; 1989 Jan; 48(1):55-60. PubMed ID: 2493386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased levels of aldose reductase in peripheral mononuclear cells from type 2 diabetic patients with microangiopathy.
    Hasegawa G; Obayashi H; Kitamura A; Hashimoto M; Shigeta H; Nakamura N; Kondo M; Nishimura CY
    Diabetes Res Clin Pract; 1999 Aug; 45(1):9-14. PubMed ID: 10499880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms of the aldose reductase locus (ALR2) and susceptibility to diabetic microvascular complications.
    Patel A; Ratanachaiyavong S; Millward BA; Demaine AG
    Adv Exp Med Biol; 1993; 328():325-32. PubMed ID: 8493909
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.